Stuart H. Johnston

2.4k citations
17 papers · 1.8k indexed · 1 hit paper · h-index 14
Topics
Melanoma and MAPK Pathways (6 papers)Computational Drug Discovery Methods (4 papers)Developmental Biology and Gene Regulation (4 papers)

In The Last Decade

Stuart H. Johnston

17 papers receiving 1.8k citations

Hit Papers

Fringe is a glycosyltransferase that modifies Notch20002026200820172000200400600

Peers

Stuart H. Johnston
Comparison fields: 5 of 90
  • Molecular Biology 1.5k
  • Oncology 221
  • Immunology 207
  • Genetics 197
  • Cell Biology 196
Replace Ernie de Boer with:
Ernie de Boer Netherlands
Hubert Condamine France
Anne E. Griep United States
Pierre Roux France
Johanna ten Hoeve United States
Vann P. Parker United States
Mari Masuda Japan
Yasuhide Yoshimura Japan
Y. Nakatani Japan
Zhenbao Yu Canada
Stuart H. Johnston relative to Ernie de Boer Netherlands Ernie de Boer's profile →
Citations per field
00.5×1.5×2.2×
Ernie de Boer · 1×
Citations per year

Countries citing papers authored by Stuart H. Johnston

Since Specialization
Citations

This map shows the geographic impact of Stuart H. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart H. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart H. Johnston more than expected).

Fields of papers citing papers by Stuart H. Johnston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart H. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart H. Johnston. The network helps show where Stuart H. Johnston may publish in the future.

Co-authorship network of co-authors of Stuart H. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart H. Johnston. A scholar is included among the top collaborators of Stuart H. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart H. Johnston. Stuart H. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 62
2 23
3 28
4 31
5 200
6 18
7 53
8
XL518, a potent selective orally bioavailable MEK1 inhibitor, downregulates the RAS/RAF/MEK/ERK pathway in vivo, resulting in tumor growth inhibition and regression in pre-clinical models
11
9 9
10
Fringe is a glycosyltransferase that modifies Notchbreakdown →
695
11 327
12 19
13 259
14 13
15 20
16 42
17 7

About Stuart H. Johnston

Stuart H. Johnston is a scholar working on Clinical Biochemistry, Computational Theory and Mathematics and Physiology, having authored 17 papers that have together received 1.8k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Computational Drug Discovery Methods (4 papers) and Developmental Biology and Gene Regulation (4 papers). The work is most often cited by research in Molecular Biology (1.5k citations), Cell Biology (196 citations) and Developmental Neuroscience (46 citations). Stuart H. Johnston has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Thomas Vogt, Richa Wilson, Kenneth D. Irvine, Jihua Chen, Yang Wang, Vladislav M. Panin, Daniel J. Moloney, Pamela Stanley, Robert S. Haltiwanger and Shao Li. Their work appears in journals such as Nature, Nature Cell Biology and Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026